Vol. 119, No. 6 NewsOpen AccessRotenone and Paraquat Linked to Parkinson’s Disease: Human Exposure Study Supports Years of Animal Studies Angela Spivey Angela Spivey Search for more papers by this author Published:1 June 2011https://doi.org/10.1289/ehp.119-a259aCited by:17AboutSectionsPDF ToolsDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InReddit A growing body of evidence suggests pesticides may play a role in Parkinson’s disease (PD) in humans. Self-reported PD has been associated with lifetime use of pesticides, and animal studies have suggested that the pesticides paraquat and rotenone can cause oxidative stress and mitochondrial dysfunction, respectively—posited mechanisms of action in PD—as well as symptoms in rodents similar to human PD. Now, researchers have linked human exposure to paraquat and rotenone with PD [EHP119(6):866–872; Tanner et al.]. Their study is the first analysis of pesticides classified by presumed mechanism of action rather than by intended use or chemical class.The researchers assessed lifetime use of pesticides as reported by participants in the Agricultural Health Study, a prospective study of private pesticide applicators (mostly farmers) and their spouses in Iowa and North Carolina. In the nested case–control study, neurologists specializing in movement disorders identified 110 people with PD and 358 controls without who were frequency matched by age, sex, and state.The researchers collected detailed information about use of 31 different pesticides as well as covariate information including lifelong smoking and family history of PD. Each pesticide was classified according to its mechanism of action as either an oxidative stressor or a mitochondrial complex I inhibitor. For participants with PD, the researchers considered pesticide use that occurred before their PD diagnosis. For controls, they considered pesticide use that occurred before the median age of PD diagnosis for cases in the corresponding age-, sex-, and state-specific groups.Among the mitochondrial complex I inhibitors studied, the researchers found the strongest association between PD and use of rotenone. Among oxidative stressors, they found the strongest association between PD and use of paraquat. Participants with PD were 2.5 times more likely than controls to have reported use of rotenone or paraquat.The results may have far-reaching implications, considering the widespread use of these pesticides. Paraquat remains one of the most widely used herbicides worldwide, and rotenone was used ubiquitously before most uses were voluntarily stopped in the United States in 2007. Other agents associated with mitochondrial complex I inhibition, such as permethrin, remain in common use.The authors point out several limitations of the study, including the fact that participants reported exposure to many pesticides, and effects of other agents can’t be excluded. However, the associations between PD and paraquat and rotenone remained after adjustment for overall pesticide use. It also was impossible to measure pesticide exposure, only estimate it retrospectively. Future investigations of combinations of pesticides and of other mechanistic groups will be important, as will mechanistic studies that model exposure conditions similar to those occurring in humans.FiguresReferencesRelatedDetailsCited by Pamies D, Block K, Lau P, Gribaldo L, Pardo C, Barreras P, Smirnova L, Wiersma D, Zhao L, Harris G, Hartung T and Hogberg H (2018) Rotenone exerts developmental neurotoxicity in a human brain spheroid model, Toxicology and Applied Pharmacology, 10.1016/j.taap.2018.02.003, Online publication date: 1-Feb-2018. Wu S, Lei L, Song Y, Liu M, Lu S, Lou D, Shi Y, Wang Z and He D (2018) Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans : the role of mitochondria-associated membrane proteins in Parkinsonism, Experimental Neurology, 10.1016/j.expneurol.2018.07.018, 309, (67-78), Online publication date: 1-Nov-2018. Liu H, Ho P, Leung G, Lam C, Pang S, Li L, Kung M, Ramsden D and Ho S (2017) Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease, Scientific Reports, 10.1038/srep40887, 7:1, Online publication date: 1-Dec-2017. Rao S, Muralidhara , Yenisetti S and Rajini P (2016) Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism, NeuroToxicology, 10.1016/j.neuro.2015.12.010, 52, (230-242), Online publication date: 1-Jan-2016. Charli A, Jin H, Anantharam V, Kanthasamy A and Kanthasamy A (2016) Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model, NeuroToxicology, 10.1016/j.neuro.2015.06.007, 53, (302-313), Online publication date: 1-Mar-2016. Bhattacharjee N and Borah A (2016) Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease, Neurochemistry International, 10.1016/j.neuint.2016.10.001, 101, (48-55), Online publication date: 1-Dec-2016. Mitra S, Chakrabarti N, Dutta S, Ray S, Bhattacharya P, Sinha P and Bhattacharyya A (2015) Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s disease, Neuroscience, 10.1016/j.neuroscience.2014.12.052, 292, (46-70), Online publication date: 1-Apr-2015. Manjunath M and Muralidhara (2013) Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster, Journal of Food Science and Technology, 10.1007/s13197-013-1219-0, 52:4, (1971-1981), Online publication date: 1-Apr-2015. Marrs T and Maynard R (2013) Neurotranmission systems as targets for toxicants: a review, Cell Biology and Toxicology, 10.1007/s10565-013-9259-9, 29:6, (381-396), Online publication date: 1-Dec-2013. Irwin M, Parameshwaran K and Pinkert C (2013) Mouse models of mitochondrial complex I dysfunction, The International Journal of Biochemistry & Cell Biology, 10.1016/j.biocel.2012.08.009, 45:1, (34-40), Online publication date: 1-Jan-2013. St. Laurent R, O’Brien L and Ahmad S (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson’s disease, Neuroscience, 10.1016/j.neuroscience.2013.04.037, 246, (382-390), Online publication date: 1-Aug-2013. Lazniewska J, Milowska K, Katir N, Kadib A, Bryszewska M, Majoral J and Gabryelak T Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line, Cellular and Molecular Biology Letters, 10.2478/s11658-013-0100-5, 18:3 Hosamani R (2013) ACUTE EXPOSURE OF Drosophila melanogaster TO PARAQUAT CAUSES OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION , Archives of Insect Biochemistry and Physiology, 10.1002/arch.21094, 83:1, (25-40), Online publication date: 1-May-2013. Sutachan J, Casas Z, Albarracin S, Stab B, Samudio I, Gonzalez J, Morales L and Barreto G (2013) Cellular and molecular mechanisms of antioxidants in Parkinson's disease, Nutritional Neuroscience, 10.1179/1476830511Y.0000000033, 15:3, (120-126), Online publication date: 1-May-2012. Parameshwaran K, Irwin M, Steliou K and Pinkert C (2012) Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brain, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2012.02.011, 101:3, (487-492), Online publication date: 1-May-2012. Jia F, Song N, Zhao C, Xie J, Jiang H and Holscher C (2014) Unexpected Improvements of Spatial Learning and Memory Abilities in Chronic Rotenone Intoxicated Mice, PLoS ONE, 10.1371/journal.pone.0091641, 9:3, (e91641) Maulik M, Mitra S, Bult-Ito A, Taylor B and Vayndorf E (2017) Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models, Frontiers in Genetics, 10.3389/fgene.2017.00077, 8 Vol. 119, No. 6 June 2011Metrics About Article Metrics Publication History Originally published1 June 2011Published in print1 June 2011 Financial disclosuresPDF download License information EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. Note to readers with disabilities EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact [email protected]. Our staff will work with you to assess and meet your accessibility needs within 3 working days.